Climb Bio, Inc. Common Stock

CLYMNASDAQ • USD
9.78 USD
↘ 0.16 (1.66%)🟢PRE MARKET (AS OF 07:16 AM EST)
🟢Market: OPEN

Shares of Climb Bio, Inc. Common Stock (CLYM) are trading at $9.78. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, CLYM appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$10.31
High?$10.75
Low?$9.19
Prev. Close?$9.94
Volume?485
Avg. Volume?1.2M
VWAP?$9.87
Rel. Volume?0.00x
Bid / Ask
Bid?$8.64 × 100
Ask?$11.47 × 100
Spread?$2.83
Midpoint?$10.06
Valuation & Ratios
Market Cap?583.9M
Shares Out?58.7M
Float?38.3M
Float %?66.7%
P/E Ratio?N/A
P/B Ratio?2.56
EPS?-$1.02
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
Employees
29
Market Cap
608.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-08-10
Address
20 WILLIAM STREET
WELLESLEY HILLS, MA
Phone: 1-866-857-2596
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
31
Piotroski F-Score?0/9Weak
Altman Z-Score?39.29Safe
Confidence?41%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?27.73%Squeeze Risk
Short Interest?10.6M
Days to Cover?7.8
Free Float38.3M
Avg Daily Volume1.4M
Settlement Date2026-10-30
Financial Health
Current Ratio?26.58Strong
Quick Ratio?26.58Strong
Cash Ratio?5.03Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
63
2.56CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-26.2%WEAK▾
ROA?
S&P
3
-25.3%WEAK▾
Cash Flow & Enterprise
FCF?$-53640000
Enterprise Value?$544.1M
Fundamentals ratios updated end of day